Duyuru • Aug 07
Medi-Caps Limited, Annual General Meeting, Sep 22, 2026 Medi-Caps Limited, Annual General Meeting, Sep 22, 2026, at 12:30 Indian Standard Time. Reported Earnings • Aug 07
First quarter 2027 earnings released: ₹1.79 loss per share (vs ₹2.80 loss in 1Q 2026) First quarter 2027 results: ₹1.79 loss per share (improved from ₹2.80 loss in 1Q 2026). Revenue: ₹28.4m (up 5.6% from 1Q 2026). Net loss: ₹22.3m (loss narrowed 36% from 1Q 2026). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Duyuru • Aug 01
Medi-Caps Limited to Report Q1, 2027 Results on Aug 06, 2026 Medi-Caps Limited announced that they will report Q1, 2027 results on Aug 06, 2026 New Risk • Jul 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). Earnings have declined by 74% per year over the past 5 years. Market cap is less than US$10m (₹331.6m market cap, or US$3.50m). Minor Risk Revenue is less than US$5m (₹124m revenue, or US$1.3m). Reported Earnings • May 23
Full year 2026 earnings released: ₹2.44 loss per share (vs ₹0.46 loss in FY 2025) Full year 2026 results: ₹2.44 loss per share (further deteriorated from ₹0.46 loss in FY 2025). Revenue: ₹206.6m (down 19% from FY 2025). Net loss: ₹30.4m (loss widened 432% from FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Duyuru • May 14
Medi-Caps Limited to Report Q4, 2026 Results on May 21, 2026 Medi-Caps Limited announced that they will report Q4, 2026 results on May 21, 2026 New Risk • May 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 71% per year over the past 5 years. Market cap is less than US$10m (₹403.5m market cap, or US$4.24m). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Revenue is less than US$5m (₹160m revenue, or US$1.7m). New Risk • Mar 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 71% per year over the past 5 years. Market cap is less than US$10m (₹313.1m market cap, or US$3.38m). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Revenue is less than US$5m (₹160m revenue, or US$1.7m). Reported Earnings • Feb 12
Third quarter 2026 earnings released: ₹0.61 loss per share (vs ₹1.64 loss in 3Q 2025) Third quarter 2026 results: ₹0.61 loss per share (improved from ₹1.64 loss in 3Q 2025). Revenue: ₹50.6m (up 26% from 3Q 2025). Net loss: ₹7.66m (loss narrowed 63% from 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Duyuru • Feb 04
Medi-Caps Limited to Report Q3, 2026 Results on Feb 11, 2026 Medi-Caps Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 11, 2026 Reported Earnings • Nov 14
Second quarter 2026 earnings released: ₹1.46 loss per share (vs ₹0.25 profit in 2Q 2025) Second quarter 2026 results: ₹1.46 loss per share (down from ₹0.25 profit in 2Q 2025). Revenue: ₹35.4m (down 57% from 2Q 2025). Net loss: ₹18.2m (down ₹21.3m from profit in 2Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance. Duyuru • Nov 04
Medi-Caps Limited to Report First Half, 2026 Results on Nov 12, 2025 Medi-Caps Limited announced that they will report first half, 2026 results on Nov 12, 2025 Reported Earnings • Aug 06
First quarter 2026 earnings released: ₹2.80 loss per share (vs ₹0.45 loss in 1Q 2025) First quarter 2026 results: ₹2.80 loss per share (further deteriorated from ₹0.45 loss in 1Q 2025). Revenue: ₹30.2m (down 51% from 1Q 2025). Net loss: ₹34.9m (loss widened ₹29.4m from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 113 percentage points per year, which is a significant difference in performance. Duyuru • Aug 05
Medi-Caps Limited, Annual General Meeting, Sep 18, 2025 Medi-Caps Limited, Annual General Meeting, Sep 18, 2025, at 12:30 Indian Standard Time. Duyuru • Jul 28
Medi-Caps Limited to Report Q1, 2026 Results on Aug 05, 2025 Medi-Caps Limited announced that they will report Q1, 2026 results on Aug 05, 2025 Reported Earnings • May 22
Full year 2025 earnings released: ₹0.46 loss per share (vs ₹1.80 loss in FY 2024) Full year 2025 results: ₹0.46 loss per share (improved from ₹1.80 loss in FY 2024). Revenue: ₹282.1m (up 3.2% from FY 2024). Net loss: ₹5.71m (loss narrowed 75% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance. Duyuru • May 14
Medi-Caps Limited to Report Q4, 2025 Results on May 21, 2025 Medi-Caps Limited announced that they will report Q4, 2025 results at 12:15 PM, Indian Standard Time on May 21, 2025 New Risk • Feb 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹589.6m market cap, or US$6.76m). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Revenue is less than US$5m (₹264m revenue, or US$3.0m). Duyuru • Feb 03
Medi-Caps Limited to Report Q3, 2025 Results on Feb 12, 2025 Medi-Caps Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 12, 2025 New Risk • Jan 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 12% per year over the past 5 years. Market cap is less than US$10m (₹722.0m market cap, or US$8.41m). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Revenue is less than US$5m (₹294m revenue, or US$3.4m). Reported Earnings • Nov 13
Second quarter 2025 earnings released: EPS: ₹0.25 (vs ₹0.09 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.25 (up from ₹0.09 in 2Q 2024). Revenue: ₹85.8m (up 42% from 2Q 2024). Net income: ₹3.12m (up 170% from 2Q 2024). Profit margin: 3.6% (up from 1.9% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 119 percentage points per year, which is a significant difference in performance. Duyuru • Nov 09
Medi-Caps Limited to Report Q2, 2025 Results on Nov 12, 2024 Medi-Caps Limited announced that they will report Q2, 2025 results on Nov 12, 2024 Reported Earnings • Aug 08
First quarter 2025 earnings released: ₹0.45 loss per share (vs ₹0.89 loss in 1Q 2024) First quarter 2025 results: ₹0.45 loss per share (improved from ₹0.89 loss in 1Q 2024). Revenue: ₹63.4m (flat on 1Q 2024). Net loss: ₹5.57m (loss narrowed 50% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance. Duyuru • Aug 07
Medi-Caps Limited, Annual General Meeting, Sep 26, 2024 Medi-Caps Limited, Annual General Meeting, Sep 26, 2024, at 12:30 Indian Standard Time. Duyuru • Aug 02
Medi-Caps Limited to Report Q1, 2025 Results on Aug 07, 2024 Medi-Caps Limited announced that they will report Q1, 2025 results on Aug 07, 2024 Duyuru • May 30
Medi-Caps Limited Announces Retirement of Mr. Pramod Fatehpuria as Independent Director Medi-Caps Limited informed that Mr. Pramod Fatehpuria (DIN: 00972389) will complete his second and final term as an Independent Director of the Company pursuant to the provisions of Sub-Section 11 of Section 149 of the Companies Act, 2013 with effect from the close of business hours on 28 May, 2024. Consequently, he will retire from Independent Directorship of the Company. Reported Earnings • May 25
Full year 2024 earnings released: ₹1.80 loss per share (vs ₹1.50 profit in FY 2023) Full year 2024 results: ₹1.80 loss per share (down from ₹1.50 profit in FY 2023). Revenue: ₹278.2m (down 44% from FY 2023). Net loss: ₹22.4m (down 220% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance. Duyuru • May 17
Medi-Caps Limited to Report Q4, 2024 Results on May 23, 2024 Medi-Caps Limited announced that they will report Q4, 2024 results on May 23, 2024 Board Change • Mar 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Gajendra Singh was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 09
Third quarter 2024 earnings released: ₹0.13 loss per share (vs ₹1.04 loss in 3Q 2023) Third quarter 2024 results: ₹0.13 loss per share (improved from ₹1.04 loss in 3Q 2023). Revenue: ₹71.6m (down 35% from 3Q 2023). Net loss: ₹1.64m (loss narrowed 87% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 14
Second quarter 2024 earnings released: EPS: ₹0.09 (vs ₹1.74 in 2Q 2023) Second quarter 2024 results: EPS: ₹0.09 (down from ₹1.74 in 2Q 2023). Revenue: ₹60.3m (down 61% from 2Q 2023). Net income: ₹1.16m (down 95% from 2Q 2023). Profit margin: 1.9% (down from 14% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings. New Risk • Nov 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹631.6m market cap, or US$7.58m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (0.3% net profit margin). Duyuru • Nov 09
Medi-Caps Limited Announces Change in Management Medi-Caps Limited announced the appointment of Mr. Akshit Garg as General Manager under the category of Senior Management Personnel. Date of Appointment: 08th November, 2023. Age 29 years. Education/Qualification:-Masters in Management and Finance from Royal Melbourne Institute of Technology, Australia. He is young and energetic having more than 5 years of experience in the field of marketing and in charge of overall business growth. He possesses great leadership and management skills and has Ability to delegate tasks, supervise others and provides utmost attention to details. He has strong interpersonal skills and a great Technological acumen. The company also announced the appointment of Mrs. Saloni Garg as Senior Manager under the category of Senior Management Personnel. Date of Appointment: 08th November, 2023. Age 28 years. Education/Qualification:- Graduate in Business Management from Mumbai Masters in Brand Management from Italy. Past experience as a Freelance Brand Manager and helping businesses find their identity, brand logos, websites, communication design and also having vast experience of day to day workings of an organization to ensure efficient performance. Duyuru • Oct 01
Medi-Caps Limited Approves Change in Designation of Gajendra Singh from Additional Director to Non Executive Independent Director Medi-Caps Limited at its AGM held on September 29, 2023 approved Change in designation of Mr. Gajendra Singh (DIN: 10253991) from Additional Director to Non Executive Independent Director. Age is 38 years. Education/Qualification is B.Com, Masters of Social work (MSW). Experience: He Possess vast experience and good exposure in strategic Management and Administration. He is well versed with optimum utilization of resources. Duyuru • Aug 30
Medi-Caps Limited, Annual General Meeting, Sep 29, 2023 Medi-Caps Limited, Annual General Meeting, Sep 29, 2023, at 12:30 Indian Standard Time. Duyuru • Aug 12
Medi-Caps Limited Appoints Gajendra Singh as an Additional Director Medi-Caps Limited announced the appointment of Mr. Gajendra Singh as an Additional Director under the category of Non Executive Independent Director. Date of Appointment is 11th August, 2023. He Possess vast experience and good exposure in strategic Management and Administration. He is well versed with optimum utilization of resources. Duyuru • Aug 05
Medi-Caps Limited to Report Q1, 2024 Results on Aug 11, 2023 Medi-Caps Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Duyuru • Jul 14
Medi-Caps Limited Announces Resignation of Akshit Garg as Non Executive Non Independent Director Medi-Caps Limited announced that Mr. Akshit Garg has received letter dated 13th July, 2023 resigned from the position of "Non Executive Non Independent Director" of the Company with effect from 21st July, 2023. Reported Earnings • May 25
Full year 2023 earnings released: EPS: ₹1.50 (vs ₹8.05 in FY 2022) Full year 2023 results: EPS: ₹1.50 (down from ₹8.05 in FY 2022). Revenue: ₹509.7m (down 27% from FY 2022). Net income: ₹18.6m (down 81% from FY 2022). Profit margin: 3.7% (down from 14% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 55% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹37.33, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 15x in the Packaging industry in India. Total returns to shareholders of 293% over the past three years. Reported Earnings • Feb 12
Third quarter 2023 earnings released: ₹1.04 loss per share (vs ₹1.67 profit in 3Q 2022) Third quarter 2023 results: ₹1.04 loss per share (down from ₹1.67 profit in 3Q 2022). Revenue: ₹110.4m (down 38% from 3Q 2022). Net loss: ₹13.0m (down 162% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Feb 02
Medi-Caps Limited to Report Q3, 2023 Results on Feb 09, 2023 Medi-Caps Limited announced that they will report Q3, 2023 results on Feb 09, 2023 Duyuru • Nov 05
Medi-Caps Limited to Report Q2, 2023 Results on Nov 10, 2022 Medi-Caps Limited announced that they will report Q2, 2023 results on Nov 10, 2022 Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹44.30, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 13x in the Packaging industry in India. Total returns to shareholders of 158% over the past three years. Duyuru • Aug 06
Medi-Caps Limited, Annual General Meeting, Sep 28, 2022 Medi-Caps Limited, Annual General Meeting, Sep 28, 2022, at 12:00 Indian Standard Time. Reported Earnings • Aug 05
First quarter 2023 earnings released: EPS: ₹0.52 (vs ₹2.63 in 1Q 2022) First quarter 2023 results: EPS: ₹0.52 (down from ₹2.63 in 1Q 2022). Revenue: ₹126.9m (down 27% from 1Q 2022). Net income: ₹6.32m (down 81% from 1Q 2022). Profit margin: 5.0% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Duyuru • Jul 28
Medi-Caps Limited to Report Q1, 2023 Results on Aug 04, 2022 Medi-Caps Limited announced that they will report Q1, 2023 results on Aug 04, 2022 Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₹43.20, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 15x in the Packaging industry in India. Total returns to shareholders of 122% over the past three years. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹8.05 (vs ₹9.02 in FY 2021) Full year 2022 results: EPS: ₹8.05 (down from ₹9.02 in FY 2021). Revenue: ₹698.7m (up 20% from FY 2021). Net income: ₹100.4m (down 11% from FY 2021). Profit margin: 14% (down from 19% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth. Duyuru • May 18
Medi-Caps Limited to Report Q4, 2022 Results on May 25, 2022 Medi-Caps Limited announced that they will report Q4, 2022 results on May 25, 2022 Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improved over the past week After last week's 16% share price gain to ₹57.00, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 14x in the Packaging industry in India. Total returns to shareholders of 279% over the past three years. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹50.55, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 14x in the Packaging industry in India. Total returns to shareholders of 288% over the past three years. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹50.55, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 14x in the Packaging industry in India. Total returns to shareholders of 288% over the past three years. Reported Earnings • Feb 13
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹1.67 (down from ₹2.75 in 3Q 2021). Revenue: ₹180.0m (down 1.5% from 3Q 2021). Net income: ₹20.8m (down 39% from 3Q 2021). Profit margin: 12% (down from 19% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 68% per year whereas the company’s share price has increased by 67% per year. Duyuru • Feb 03
Medi-Caps Limited to Report Q3, 2022 Results on Feb 10, 2022 Medi-Caps Limited announced that they will report Q3, 2022 results on Feb 10, 2022 Reported Earnings • Nov 12
Second quarter 2022 earnings released: EPS ₹2.59 (vs ₹2.94 in 2Q 2021) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹174.4m (up 17% from 2Q 2021). Net income: ₹32.3m (up 3.3% from 2Q 2021). Profit margin: 19% (down from 21% in 2Q 2021). The decrease in margin was driven by higher expenses. Reported Earnings • Jun 29
Full year 2021 earnings released: EPS ₹11.16 (vs ₹4.69 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹593.0m (up 33% from FY 2020). Net income: ₹112.4m (up ₹171.0m from FY 2020). Profit margin: 19% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 25
Investor sentiment improved over the past week After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 14x in the Packaging industry in India. Total returns to shareholders of 134% over the past three years. Valuation Update With 7 Day Price Move • Mar 06
Investor sentiment improved over the past week After last week's 19% share price gain to ₹35.00, the stock is trading at a trailing P/E ratio of 3x, up from the previous P/E ratio of 2.5x. This compares to an average P/E of 10x in the Packaging industry in India. Total returns to shareholders over the past three years are 51%. Is New 90 Day High Low • Mar 05
New 90-day high: ₹35.00 The company is up 54% from its price of ₹22.75 on 04 December 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 4.0% over the same period. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improved over the past week After last week's 42% share price gain to ₹34.80, the stock is trading at a trailing P/E ratio of 3x, up from the previous P/E ratio of 2.1x. This compares to an average P/E of 10x in the Packaging industry in India. Total returns to shareholders over the past three years are 35%. Is New 90 Day High Low • Feb 08
New 90-day high: ₹29.45 The company is up 33% from its price of ₹22.10 on 10 November 2020. The Indian market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 5.0% over the same period. Duyuru • Feb 06
Medi-Caps Limited Appoints Dharmendra Solanki as an Additional as Well as Non Executive Independent Director Medi-Caps Limited at its board meeting held on February 5, 2021 approved the appointment of Dharmendra Solanki as an additional as well as non executive independent Director in the company. Reported Earnings • Feb 06
Third quarter 2021 earnings released: EPS ₹3.54 (vs ₹2.63 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹182.7m (up 114% from 3Q 2020). Net income: ₹34.3m (up ₹67.5m from 3Q 2020). Profit margin: 19% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Duyuru • Feb 01
Medi-Caps Limited to Report Q3, 2021 Results on Feb 05, 2021 Medi-Caps Limited announced that they will report Q3, 2021 results on Feb 05, 2021 Is New 90 Day High Low • Dec 09
New 90-day high: ₹24.65 The company is up 23% from its price of ₹20.05 on 10 September 2020. The Indian market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 10.0% over the same period. Duyuru • Nov 25
Medi-Caps Limited Announces Demise of Shamsher Singh, Non-Executive Independent Director Medi-Caps Limited announced sudden and sad demise of Mr. Shamsher Singh, Non-Executive Independent Director of the Company, on 20 November, 2020. Mr. Shamsher Singh was on the Board of the Company since April 30, 2002 and the Company immensely benefitted from his vision and contribution during his tenure. Is New 90 Day High Low • Nov 12
New 90-day high: ₹23.95 The company is up 9.0% from its price of ₹21.90 on 14 August 2020. The Indian market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Packaging industry, which is down 2.0% over the same period. Duyuru • Oct 30
Medi-Caps Limited to Report Q2, 2021 Results on Nov 06, 2020 Medi-Caps Limited announced that they will report Q2, 2021 results on Nov 06, 2020 Duyuru • Jun 21
Medi-Caps Limited to Report Q4, 2020 Results on Jun 26, 2020 Medi-Caps Limited announced that they will report Q4, 2020 results on Jun 26, 2020